Beam Therapeutics Inc. (NASDAQ: BEAM) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BEAM THERAPEUTICS INC.

Beam Therapeutics Inc. (NASDAQ: BEAM)
Listen to this Section


$27.02
+0.6850 ( +2.60% ) 967.0K

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Market Data


Open $27.02
Previous Close $26.33
Volume 967.0K
Market Cap $2.71B
Day Range $26.11 - $27.77
52 Week Range $15.60 - $38.26
Shares Outstanding 102.88M
Change % +2.60%
Net Change ▲ 0.6850
Insider Ownership -0.03%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -893,047.00

Date Type Amount Purchased Purchaser
2024-07-03 Sale -502.00 Simon Amy
2024-06-28 Sale -60000.00 Evans John M.
2024-06-07 Sale -23114.00 Shaw Christi
2024-06-07 Sale -23114.00 Ho Carole
2024-06-07 Sale -23114.00 MARAGANORE JOHN
2024-06-07 Sale -23114.00 Walsh Kathleen E
2024-06-07 Sale -23114.00 COOPER GRAHAM K
2024-06-07 Sale -23114.00 Fishman Mark
2024-04-29 Sale -12500.00 Burrell Terry-Ann
2024-04-03 Sale -5446.00 Burrell Terry-Ann

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 03, 2025
8-k 8K-related 10 Jul 03, 2025

Latest News